NZOZ Nr.1 Bukowa Sp. Z.O.O.
- Address
- ul. Zamostna 3a, 84-239 Bolszewo, Poland
NZOZ Nr.1 Bukowa Sp. Z.O.O.
NZOZ Nr.1 Bukowa Sp. Z.O.O. is a clinical research facility specializing in dermatological manifestations of systemic diseases, with particular expertise in chronic kidney disease-associated pruritus (CKD-aP). The center conducts rigorous double-blind, randomized controlled trials evaluating novel therapeutic interventions for patients suffering from chronic conditions that affect both renal function and skin health.
- Chronic kidney disease-associated pruritus treatment studies
- Topical dermatological therapy evaluation
- Quality of life assessments in patients with systemic disease complications
The research center demonstrates proficiency in conducting parallel-group clinical trials with robust methodological design, focusing on both efficacy and safety outcomes over extended treatment periods. Their work contributes to addressing the significant unmet medical needs of patients experiencing debilitating pruritus secondary to chronic kidney disease, a condition that substantially impacts patient quality of life and often lacks effective treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NZOZ Nr.1 Bukowa Sp. Z.O.O.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Subjects with Chronic Kidney Disease-associated Pruritus (CKD-aP) | Mc2 Therapeutics Limited | Phase II | Not Recruiting | Feb 2023 | Feb 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alanyl Glutamine | 1 | Unknown | 2023-02-20 | 2023-02-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.